Employer cardiometabolic program combining behavior-change coaching with digital support for GLP-1 users.
Dario Weight Management is DarioHealth's employer and health-plan offering for members using GLP-1 and anti-obesity medicines. It combines whole-health behavior-change coaching with digital tracking and adherence insights for plan sponsors.
The program serves employers and health plans managing cardiometabolic populations, pairing medication support with coaching and engagement data aimed at sustained outcomes and controlled spend.
| Attribute | Dario Weight Management | EmblaThriveMD | |
|---|---|---|---|
| Provider |  |  | |
| Founded | 2011 | 2021 | |
| Sells To | Consumers | — | |
| Pricing Model | Recurring, Software | — | |
| Ownership | Public | — |
Provider
Founded 2011
Sells To Consumers
Pricing Model Recurring, Software
Ownership Public
Provider
Founded 2021
Sells To —
Pricing Model —
Ownership —
Goodpath's employer-facing GLP-1 care program, pairing direct-to-employer medication pricing with clinical support.
Goodpath's employer-facing GLP-1 care program, pairing direct-to-employer medication pricing with clinical support.
Clinical weight-management support integrated with Rightway's pharmacy benefits for employers.
Clinical weight-management support integrated with Rightway's pharmacy benefits for employers.
Omada for Prevention & Weight Health provides virtual coaching for weight and metabolic risk management.
Weight Loss by Hers is a membership program prescribing GLP-1 medication to eligible women with nutrition and care-team support.
Weight-loss offering combining oral or injectable GLP-1 prescribing with nutrition-first care and a provider-led deprescription pathway.
Omada for Prevention & Weight Health provides virtual coaching for weight and metabolic risk management.
Lark provides digital coaching and connected devices for cardiometabolic health management.
Weight Loss by Hers is a membership program prescribing GLP-1 medication to eligible women with nutrition and care-team support.
Weight-loss offering combining oral or injectable GLP-1 prescribing with nutrition-first care and a provider-led deprescription pathway.
